ArticleThoracic research and practice2026
CT Histogram Analysis for Predicting Malignancy in Anterior Mediastinal Masses.
Article in Thoracic research and practice, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveAnterior mediastinal masses encompass a broad spectrum from benign thymic hyperplasia to malignant thymomas and thymic complementary computed tomography (CT) histogram and texture analysis have emerged as complementary, non-invasive quantitative biomarkers for malignancy prediction. This study investigates whether CT histogram-derived parameters, particularly mean attenuation and first-order metrics, can differentiate benign from malignant anterior mediastinal masses to support preoperative risk stratification. MATERIAL AND
methodsWe retrospectively analyzed data from 102 patients who underwent surgical resection of anterior mediastinal masses. Non-contrast CT scans were evaluated, and mean Hounsfield unit (HU), standard deviation, skewness, and kurtosis values were extracted using region-of-interest-based histogram analysis. Histopathological diagnosis is considered the gold standard for classification. Group comparisons were performed using appropriate parametric or non-parametric tests, and the diagnostic performance was evaluated using receiver operating characteristic (ROC) analysis.
resultsOf the 102 patients, 60 (58.8%) had malignant and 42 (41.2%) had benign pathologies. The mean CT attenuation was higher in malignant lesions than in benign lesions (63.3±16.9 HU vs. 48.3±39.0 HU;
conclusionCT histogram analysis, particularly mean attenuation, may serve as a complementary biomarker for differentiating benign from malignant anterior mediastinal masses. Given its high sensitivity but limited specificity, it should be used as an adjunct to clinical and morphologic assessment rather than as a determinant of surgical management. Prospective validation incorporating volumetric and advanced radiomic parameters is required.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.